Sichenzia Ross Ference represented Laidlaw & Company (UK) Ltd. în the transaction while Sheppard Mullin advised Silo Pharma. Silo Pharma, Inc. (Nasdaq: SILO) announced the $5.75 million...
Silo Pharma’s $5.75 Million Public Offering and Nasdaq Uplisting
FoxWayne Enterprises Acquisition Corp.’s Business Combination with Clover
Sheppard Mullin represented FoxWayne Enterprises Acquisition Corp. on the deal. FoxWayne Enterprises Acquisition Corp., a special purpose acquisition company (SPAC), announced its recently announced proposed business combination...
FoxWayne Enterprises Acquisition Corp.’s Business Combination with Clover
Sheppard Mullin represented FoxWayne Enterprises Acquisition Corp. on the deal. FoxWayne Enterprises Acquisition Corp., a special purpose acquisition company (SPAC), announced its recently announced proposed business combination...
Amesite’s $2.3 Million Direct Offering and Private Placement
Sichenzia Ross Ference LLP represented Laidlaw & Company on the deal while Sheppard Mullin advised Amesite. Amesite Inc announced a registered direct offering of 4,181,821 shares of...